Sarcoma / 2018 / Article / Tab 2

Review Article

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy

Table 2

Currently recruiting clinical trials of intratumoral immunotherapy in soft tissue sarcoma.

TreatmentPhaseClinicalTrials.gov identifier

HSV-1 M002 (IT or IV)INCT00931931
HSV-1 M002 + concurrent radiationI/IINCT02453191
HSV-1 M002 + pembrolizumabIINCT03069378
TVEC + preoperative radiationI/IINCT02453191
JX-594 + cyclophosphamideI/IINCT02630368
TTI-621INCT02890368
INTUVAXINCT02686944
Poly-ICLCIINCT01984892
Clostridium novyi-NT sporesINCT01924689

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.